Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-May-24 4:24 PM View:  | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 01-May-24 | Option Exercise | 10,000 | $0.60 | $6,000.00 | 402% 2.48K to 12.48K | |
| 03-May-24 4:24 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 01-May-24 | Planned Option Sale | 10,000 | $11.37 | $113,653.00 | (80%) 12.48K to 2.48K | |
| 18-Apr-24 4:16 PM View: | Skorpios Trust 10% Owner | Stoke Therapeutics, Inc. (STOK) | 17-Apr-24 | Sale | 3,600,000 | $11.60 | $41,760,000.00 | (25%) 14.44M to 10.84M | |
| 03-Apr-24 4:19 PM View: | Nash Huw M. COO & CBO | Stoke Therapeutics, Inc. (STOK) | 01-Apr-24 | Option Exercise | 50,000 | $0.40 | $20,000.00 | 441% 11.33K to 61.33K | |
| 03-Apr-24 4:19 PM View: | Nash Huw M. COO & CBO | Stoke Therapeutics, Inc. (STOK) | 01-Apr-24 | Sale (Planned) | 11,329 | $13.23 | $149,851.00 | (100%) 11.33K to 0 | |
| 03-Apr-24 4:21 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 01-Apr-24 | Planned Option Sale | 442 | $13.23 | $5,846.64 | (4%) 11.91K to 11.47K | |
| 03-Apr-24 4:21 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 01-Apr-24 | Sale (Planned) | 8,984 | $13.23 | $118,838.00 | (78%) 11.47K to 2.48K | |
| 03-Apr-24 4:19 PM View: | Nash Huw M. COO & CBO | Stoke Therapeutics, Inc. (STOK) | 01-Apr-24 | Planned Option Sale | 50,000 | $13.23 | $661,361.00 | (82%) 61.33K to 11.33K | |
| 03-Apr-24 4:21 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 01-Apr-24 | Option Exercise | 442 | $0.60 | $265.20 | 4% 11.47K to 11.91K | |
| 01-Apr-24 4:14 PM View: | Allan Jonathan General Counsel & Corp Sec | Stoke Therapeutics, Inc. (STOK) | 28-Mar-24 | Sale (Planned) | 5,126 | $13.20 | $67,667.90 | (66%) 7.72K to 2.6K | |
| 19-Mar-24 8:34 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 19-Mar-24 | Option Sale | 4,116 | $6.10 | $25,101.80 | (26%) 15.59K to 11.47K | |
| 19-Mar-24 8:36 PM View: | Tulipano Stephen J CFO | Stoke Therapeutics, Inc. (STOK) | 19-Mar-24 | Option Sale | 4,116 | $6.10 | $25,101.80 | (17%) 24.86K to 20.75K | |
| 19-Mar-24 8:31 PM View: | Nash Huw M. COO & CBO | Stoke Therapeutics, Inc. (STOK) | 19-Mar-24 | Option Sale | 4,116 | $6.10 | $25,101.80 | (27%) 15.45K to 11.33K | |
| 19-Mar-24 8:29 PM View: | Allan Jonathan General Counsel & Corp Sec | Stoke Therapeutics, Inc. (STOK) | 19-Mar-24 | Option Sale | 2,349 | $6.10 | $14,325.60 | (23%) 10.07K to 7.72K | |
| 19-Mar-24 8:30 PM View: | Kaye Edward M. Md CEO Director | Stoke Therapeutics, Inc. (STOK) | 19-Mar-24 | Option Sale | 11,150 | $6.10 | $67,999.40 | (14%) 80.5K to 69.35K | |
| 19-Mar-24 8:29 PM View: | Allan Jonathan General Counsel & Corp Sec | Stoke Therapeutics, Inc. (STOK) | 15-Mar-24 | Option Exercise | 7,475 | -- | -- | 288% 2.6K to 10.07K | |
| 19-Mar-24 8:30 PM View: | Kaye Edward M. Md CEO Director | Stoke Therapeutics, Inc. (STOK) | 15-Mar-24 | Option Exercise | 35,500 | -- | -- | 79% 45.0K to 80.5K | |
| 19-Mar-24 8:34 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 15-Mar-24 | Option Exercise | 13,100 | -- | -- | 527% 2.48K to 15.59K | |
| 19-Mar-24 8:31 PM View: | Nash Huw M. COO & CBO | Stoke Therapeutics, Inc. (STOK) | 15-Mar-24 | Option Exercise | 13,100 | -- | -- | 559% 2.35K to 15.45K | |
| 19-Mar-24 8:36 PM View: | Tulipano Stephen J CFO | Stoke Therapeutics, Inc. (STOK) | 15-Mar-24 | Option Exercise | 13,100 | -- | -- | 111% 11.76K to 24.86K | |
| 05-Mar-24 4:21 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 01-Mar-24 | Option Exercise | 5,504 | $0.60 | $3,302.40 | 79% 6.98K to 12.48K | |
| 05-Mar-24 4:21 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 01-Mar-24 | Planned Option Sale | 5,504 | $7.75 | $42,638.90 | (44%) 12.48K to 6.98K | |
| 05-Mar-24 4:21 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 01-Mar-24 | Sale (Planned) | 4,496 | $7.75 | $34,830.10 | (64%) 6.98K to 2.48K | |
| 15-Feb-24 4:17 PM View: | Tzianabos Arthur Director | Stoke Therapeutics, Inc. (STOK) | 13-Feb-24 | Option Exercise | 31,739 | $2.19 | $69,508.40 | 100% 0 to 31.74K | |
| 05-Feb-24 4:32 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 01-Feb-24 | Sale (Planned) | 10,000 | $4.80 | $47,991.00 | (59%) 16.98K to 6.98K | |
| 04-Jan-24 4:38 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 02-Jan-24 | Sale (Planned) | 10,000 | $5.74 | $57,352.00 | (37%) 26.98K to 16.98K | |
| 06-Jul-23 5:20 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 03-Jul-23 | Sale (Planned) | 15,000 | $10.60 | $158,973.00 | (37%) 40.9K to 25.89K | |
| 23-Jun-23 4:45 PM View: | Allan Jonathan General Counsel & Corp Sec | Stoke Therapeutics, Inc. (STOK) | 21-Jun-23 | Sale (Planned) | 1,948 | $13.48 | $26,252.20 | (100%) 1.95K to 0 | |
| 05-Jun-23 7:31 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 01-Jun-23 | Sale (Planned) | 15,000 | $11.13 | $166,964.00 | (27%) 55.9K to 40.9K | |
| 08-May-23 7:35 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 04-May-23 | Sale (Planned) | 653 | $10.00 | $6,530.00 | (1%) 56.55K to 55.9K | |
| 03-May-23 10:00 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 03-May-23 | Sale (Planned) | 24,697 | $10.14 | $250,366.00 | (30%) 81.25K to 56.55K | |
| 03-May-23 10:00 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 02-May-23 | Sale (Planned) | 5,513 | $10.00 | $55,133.90 | (6%) 86.76K to 81.25K | |
| 03-May-23 10:00 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 01-May-23 | Sale (Planned) | 24,967 | $10.00 | $249,767.00 | (22%) 111.72K to 86.76K | |
| 08-Sep-23 4:15 PM View: | Kaye Edward M. Md CEO Director | Stoke Therapeutics, Inc. (STOK) | 27-Mar-23 | Option Exercise | 20,000 | $0.60 | $12,000.00 | 80% 25.0K to 45.0K | |
| 07-Feb-23 5:08 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 06-Feb-23 | Sale (Planned) | 9,235 | $10.02 | $92,491.30 | (8%) 120.96K to 111.72K | |
| 07-Feb-23 5:08 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 03-Feb-23 | Sale (Planned) | 3,763 | $10.03 | $37,745.10 | (3%) 124.72K to 120.96K | |
| 02-Feb-23 6:32 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 02-Feb-23 | Sale (Planned) | 267 | $10.00 | $2,670.00 | (< 1%) 124.99K to 124.72K | |
| 02-Feb-23 6:32 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 01-Feb-23 | Sale (Planned) | 5,705 | $10.02 | $57,140.10 | (4%) 130.69K to 124.99K | |
| 02-Feb-23 6:32 PM View: | Ticho Barry Chief Medical Officer | Stoke Therapeutics, Inc. (STOK) | 31-Jan-23 | Sale (Planned) | 200 | $10.00 | $2,000.00 | (< 1%) 130.9K to 130.69K | |
| 03-Jun-22 5:00 PM View: | Tulipano Stephen J CFO | Stoke Therapeutics, Inc. (STOK) | 02-Jun-22 | Option Exercise | 11,160 | $4.48 | $49,996.80 | 1854% 0.6K to 11.76K | |
| 26-May-22 5:16 PM View: | Kaye Edward M. Md CEO Director | Stoke Therapeutics, Inc. (STOK) | 25-May-22 | Option Exercise | 15,000 | $0.60 | $9,000.00 | 150% 10.0K to 25.0K | |
| 05-Jan-22 5:35 PM View: | Nash Huw M. COO & CBO | Stoke Therapeutics, Inc. (STOK) | 03-Jan-22 | Option Exercise | 3,800 | $2.19 | $8,322.00 | 100% 0 to 3.8K | |
| 05-Jan-22 5:35 PM View: | Nash Huw M. COO & CBO | Stoke Therapeutics, Inc. (STOK) | 03-Jan-22 | Market Option Sale (Planned) | 3,800 | $23.07 | $87,666.10 | (100%) 3.8K to 0 | |
| 03-Dec-21 6:15 PM View: | Nash Huw M. COO & CBO | Stoke Therapeutics, Inc. (STOK) | 01-Dec-21 | Market Option Sale (Planned) | 5,700 | $24.44 | $139,330.00 | (100%) 5.7K to 0 | |
| 03-Dec-21 6:15 PM View: | Nash Huw M. COO & CBO | Stoke Therapeutics, Inc. (STOK) | 01-Dec-21 | Option Exercise | 5,700 | $2.19 | $12,483.00 | 100% 0 to 5.7K | |
| 03-Nov-21 6:05 PM View: | Nash Huw M. COO & CBO | Stoke Therapeutics, Inc. (STOK) | 03-Nov-21 | Option Exercise | 1,900 | $2.19 | $4,161.00 | 100% 0 to 1.9K | |
| 03-Nov-21 6:05 PM View: | Nash Huw M. COO & CBO | Stoke Therapeutics, Inc. (STOK) | 03-Nov-21 | Market Option Sale (Planned) | 1,900 | $25.00 | $47,500.00 | (100%) 1.9K to 0 | (6%) |
| 03-Nov-21 6:05 PM View: | Nash Huw M. COO & CBO | Stoke Therapeutics, Inc. (STOK) | 01-Nov-21 | Option Exercise | 3,800 | $2.19 | $8,322.00 | 100% 0 to 3.8K | |
| 03-Nov-21 6:05 PM View: | Nash Huw M. COO & CBO | Stoke Therapeutics, Inc. (STOK) | 01-Nov-21 | Market Option Sale (Planned) | 3,800 | $23.54 | $89,456.50 | (100%) 3.8K to 0 | (13%) |
| 04-Oct-21 5:51 PM View: | Nash Huw M. COO & CBO | Stoke Therapeutics, Inc. (STOK) | 01-Oct-21 | Option Exercise | 5,700 | $2.19 | $12,483.00 | 100% 0 to 5.7K |
